Business Context and Reporting Period
This Form 8-K reports on the 2020 Annual Meeting of Stockholders held by OrthoPediatrics Corp. on June 3, 2020. The company is incorporated in Delaware and its common stock trades on the Nasdaq Global Market under the symbol "KIDS."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on the election of directors and the ratification of the independent auditor. The results were as follows:
- Election of Directors: All four nominees were elected to serve until the 2023 Annual Meeting.
- David R. Pelizzon: 9,534,491 votes for; 4,330,653 withheld.
- Harald Ruf: 10,574,983 votes for; 3,290,161 withheld.
- Terry D. Schlotterback: 10,211,561 votes for; 3,653,583 withheld.
- Kevin L. Unger: 10,859,879 votes for; 3,005,265 withheld.
- Ratification of Auditor: Stockholders ratified the selection of Deloitte & Touche LLP for the fiscal year ending December 31, 2020.
- For: 14,908,650
- Against: 112,253
- Abstain: 1,750
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the term length of the newly elected directors (until the 2023 Annual Meeting).
- Confirm the appointment of Deloitte & Touche LLP as the independent auditor for the 2020 fiscal year.
- Note the significant number of votes withheld for director David R. Pelizzon compared to other nominees.
- Review the company's status as an emerging growth company that has elected not to use the extended transition period for new accounting standards.